Kevin S. Boyle Sr.

Chief Executive Officer, ZIOPHARM Oncology.

Companies

ZIOPHARM OncologyBoard member Aug 31, 2021 to Sep 5, 2023¹
ZIOPHARM OncologyChief executive officer Aug 31, 2021 to Sep 5, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

ZIOPHARM Oncology TCRT798,236 shares²$2.5M at $3.08Sep 1, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 1, 2023Sold 68,014 shares at $0.14 of ZIOPHARM Oncology²
Aug 30, 2022Shares withheld for tax 18,750 shares at $2.41 of ZIOPHARM Oncology³
Nov 17, 2021Bought 9,116 shares at $1.40 of ZIOPHARM Oncology⁴
Nov 16, 2021Bought 884 shares at $1.40 of ZIOPHARM Oncology⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARZIOPHARM Oncology, Board member
2
SEC EDGARZIOPHARM Oncology shares after the filing of Sep 1, 2023
3
SEC EDGARForm 4 filed Sep 1, 2022
4
SEC EDGARForm 4 filed Nov 17, 2021